Public Company News
Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy
SHANGHAI, April 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary cancers and related major diseases, announced its 2021 annual report today. The company is currently making steady progress in mu...
2022-04-14 22:49
3325
Zhihu Inc. Announces Pricing of Global Offering
BEIJING, April 14, 2022 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH) ("Zhihu" or the "Company"), the operator of Zhihu, a leading online content community inChina, today announced the pricing of the global offering (the "Global Offering") of 26,000,000 Class A ordinary shares of the Company (the "Sale S...
2022-04-14 21:27
5149
Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dual-targeting CAR-T Cell Therapy, Accepted for Presentation at 2022 ASCO Annual Meeting
PALO ALTO, Calif. and SUZHOU, China, April 14, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
2022-04-14 20:30
2971
Ambow Receives MoE Approval for 174 University Collaborative Projects
BEIJING, April 14, 2022 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE American: AMBO), a leading cross-border career educational and technology service provider, today announced that 174 of its university collaboration projects were listed in the Approved Projects ...
2022-04-14 20:30
2534
The Push for Glory Continues as Color Star's partner team Villarreal CF advances to the Semi-Finals of the UEFA Champions League
NEW YORK, April 14, 2022 /PRNewswire/ -- Color Star Technology Co., Ltd. (Nasdaq: CSCW) ("Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence in the entertainment industry, announces ...
2022-04-14 20:30
2655
China Medical System (0867.HK): the Leader in Commercialization Embraces Great Industry Opportunities as Biotech Companies are Eager to Monetize Their Innovative Products
HONG KONG, April 14, 2022 /PRNewswire/ -- Recently, China Medical System ("CMS", 0867.HK) announced its annual results. After recording continuous performance growth in the difficult time of the pandemic in 2020, it once again achieved a new record high, with revenue ofRMB 8,337 million, up 20.0%...
2022-04-14 20:24
2186
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control
SHANGHAI, April 14, 2022 /PRNewswire/ -- April 13, 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH, 02196.HK) announced that the Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) self-developed by Fosun Diagnostics Co....
2022-04-14 19:45
3463
Sharing Economy Appoints Jefferson Chan as Chairman and CEO
HONG KONG, April 14, 2022 /PRNewswire/ -- Sharing Economy International Inc. ("SEII") (OTCQB: SEII), announced today that the board of directors has appointed Mr.Pak Hei Jefferson Chan to be the Chairman and CEO, after Mr. Anthony Che Chung Chan has resigned as Chairman and CEO. Mr. Jefferson Ch...
2022-04-14 19:20
5720
MTU Yuchai Power Announces Major Production Milestone
SINGAPORE, April 14, 2022 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") a leading manufacturer and distributor of engines for on- and off-road applications inChina through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited ("...
2022-04-14 18:00
3154
CBAK Energy Reports Fourth Quarter and Full Year 2021 Unaudited Financial Results
--Net Revenues up 80% year over year in the fourth quarter – --Full-Year Net Revenues up 40% year over year in 2021– --CBAK Energy turns to profitability in 2021 DALIAN, China, April 14, 2022 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading ...
2022-04-14 17:30
4851
Qudian Inc. Announces Strategic Business Initiative
- Launching Ready-to-Cook Meal Business Nationwide - XIAMEN, China, April 14, 2022 /PRNewswire/ -- Qudian Inc. ("Qudian" or the "Company") (NYSE: QD), a consumer-oriented technology company in China, today announced it has launched a new strategic business initiative in ready-to-cook meals, or Q...
2022-04-14 17:00
5721
iQIYI Announces Changes to Board Composition
BEIJING, April 14, 2022 /PRNewswire/ -- iQIYI, Inc. (Nasdaq: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service in China, today announced changes to its board composition. Mr. Conor Chia-hung Yang, has been appointed as an independent director of the board of...
2022-04-14 17:00
2821
Onion Global Announces Upgraded "Supply-to-Business" Strategy Integrating Upstream Supply Chain and Expanding B2B Customer Base
GUANGZHOU, China, April 14, 2022 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that incubates, markets, and distributes the world's fresh, fashionable, and future brands to young people inChina and across...
2022-04-14 16:00
4506
Akeso Publishes Preclinical Results of PD-1/LAG-3 Bi-specific Antibody（AK129）at the American Association for Cancer Research (AACR) 2022 Annual Meeting
HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its PD-1/LAG-3...
2022-04-14 15:39
2711
Akeso Publishes Preclinical Results of PD-1/CD73 Bi-specific Antibody（AK131）at the American Association for Cancer Research (AACR) 2022 Annual Meeting
HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its PD-1/CD73 ...
2022-04-14 15:05
2389
Akeso Publishes Preclinical Results of TIGIT monoclonal antibody（AK127）at the American Association for Cancer Research (AACR) 2022 Annual Meeting
HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its anti-TIGIT...
2022-04-14 14:54
2607
Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer
CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 13, 2022 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), today announced the appointment of Dr.Humphrey Gardner as Chief Medical Officer (CMO). Dr. Gardner will be responsible for leading the global product d...
2022-04-14 08:46
2263
AACR 2022 | Ascentage Pharma Presents Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
SUZHOU, China and ROCKVILLE, Md., April 13, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has presented the latest results from six...
2022-04-14 08:28
2687
Origin Agritech to Host First Half 2022 Earning Conference Call
BEIJING, April 13, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today announced that it will file its first half 2022 financial results onThursday, May 5, 2022 before the market open and will host a conference call that s...
2022-04-14 02:51
2613
LiveHire Direct Sourcing and Talent Pooling Platform Now Available on SAP® Store
By integrating with the SAP® Fieldglass® Contingent Management solution, LiveHire's platform supports customers to attract, curate and engage the best contingent talent. MIAMI, April 13, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-service (SaaS) platform connecting comp...
2022-04-14 01:43
2814
Week's Top Stories
Most Reposted
Visa and Mintoak Join Forces to Bring Merchant SaaS Capabilities to Acquirers Across Asia Pacific
[Picked up by 313 media titles]
2026-06-17 11:00NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia
[Picked up by 302 media titles]
2026-06-19 11:12
Affinidi and CardInfoLink Put the Missing Trust Layer for AI Agents into Production
[Picked up by 301 media titles]
2026-06-19 09:00
IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
[Picked up by 298 media titles]
2026-06-22 17:40
Most Read
All Eyes on Korea: CSOP KOSPI 200 ETF (3121.HK) to List on HKEX Tomorrow
2026-06-17 21:17
6454
